Tri-Service Buprenorphine Training Defense Health Agency and Walter Reed National Military Medical Center 10 February 2016 4 May 2016 3 August 2016 2 November 2016 Agenda: Overview, Review of Opioids Introduction to Buprenorphine Confidentiality and Urine Drug Testing Special Populations Overview Opioid Use Disorder Patient Evaluation, Clinical uses   Course Director: Christopher Spevak MD MPH JD Director Prescription Medication Misuse Program   This course, free of charge, provides the required 8 hours of training necessary to apply for the DEA waiver. Participants complete 4 hours of home study followed by 4 hour webinar 1300 – 1700 (ET) It also acts as a refresher in evidence-based practices for prescribing Buprenorphine in the treatment of opioid addiction. For additional information or to register, contact DHA.SUD@Engilitycorp.com. Accreditation Statement: This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of the U.S. Navy Medical Command and WRNMMC. The U.S. Navy Medical Command is accredited by the ACCME to provide continuing medical education for physicians. Credit Designation: AMA PRA Category 1 Credit(s)™pending  Funding for this initiative was made possible (in part) by Providers’ Clinical Support System for Medication Assisted Treatment (1U79TI024697) from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. DATA Sponsor: The American Academy of Addiction Psychiatry